Case Activity (204888)

1. Response | Filed: July 09, 2026 | Entered: July 09, 2026 Hollingsworth v. Sanofi-Aventis US LLC et al

   Civil Rights: Other | Oregon

   Objections to Findings & Recommendation

   Objections (Defendants' Response to Plaintiff's Objections to Findings & Recommendation) to Findings & Recommendation: Motion to Dismiss for Failure to State a Claim or, in the Alternative (2) Motion to Strike Plaintiff's Complaint or, in the Alternative (3) Motion to Compel Arbitration 14 , Motion to Dismiss Fi 43 . Filed by Chattem Inc., Quten Research Institute LLC, Sanofi-Aventis US LLC. (Tuttle, Helen)

2. Minutes | Filed: July 09, 2026 | Entered: July 09, 2026 Mosaic Health, Inc. v. Sanofi-Aventis U.S., LLC et al

   Anti-Trust | New York Western

   Discovery Hearing

   Minute entry for proceedings held before Hon. Colleen D. Holland. Discovery conference held on 7/9/2026. The parties are directed to confer and notify the Court as to a date and time in September for a case management conference in this matter. The Court hears argument as to the parties' dispute regarding ex parte contact with former employees. The Court takes a recess to permit counsel to confer as to whether they would like the opportunity to make additional formal written submissions regarding the issue. When the Court reconvenes, both sides advise that they are not requesting to make further written submissions. The Court will takes the issue under advisement and will issue a decision at its earliest convenience. Appearances: Brian Feldman, Esq., Adam Shaw, Esq., Christina Deats, Esq., and Nyran Rasche, Esq., for Plaintiff; Ross Elfand, Esq., and Kathryne Hunter, Esq.,for Novo Nordisk Inc.; Aaron Healy, Esq., for Sanofi-Aventis U.S., LLC.; Matthew Tabas, Esq., and Kyle Gooch, Esq., for AstraZeneca Pharmaceuticals LP; Thomas DAntonio, Esq., for Eli Lilly and Company and Lilly USA, LLC; Daniel Laytin, Esq., for all Defendants. (Court Reporter FTR Gold.) (DAF)

3. 204886 additional result(s)